NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
57.78
+0.21 (+0.36%)
As of 10:34AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close57.57
Open57.38
Bid57.65 x 1000
Ask57.85 x 900
Day's Range57.38 - 57.86
52 Week Range43.51 - 72.41
Volume11,367
Avg. Volume409,198
Market Cap3.041B
Beta (3Y Monthly)1.24
PE Ratio (TTM)61.93
EPS (TTM)0.93
Earnings DateJul 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est61.67
Trade prices are not sourced from all markets
  • Henry Schein Closes Acquisition of Elite Computer Italia
    Zacksyesterday

    Henry Schein Closes Acquisition of Elite Computer Italia

    The Elite Computer acquisition marks Henry Schein's (HSIC) foray into the Italian dental practice management software market.

  • NextGen Inks Deal With Appriss Health, Boosts EHR System
    Zacksyesterday

    NextGen Inks Deal With Appriss Health, Boosts EHR System

    NextGen (NXGN) integrates Appriss Health prescription monitoring and tracking analytics into NextGen Office that is likely to enhance the former's EHR system.

  • Intuitive Surgical to Boost da Vinci Platform With Buyout
    Zacks2 days ago

    Intuitive Surgical to Boost da Vinci Platform With Buyout

    Intuitive Surgical's (ISRG) acquisition of Scholly Fiberoptic's robotic endoscope business to likely boost the acquirer's da Vinci Surgical system.

  • Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak
    Zacks2 days ago

    Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak

    Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.

  • Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers
    Zacks2 days ago

    Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers

    Masimo (MASI) gains from expansion of product portfolio and recent regulatory approvals.

  • Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand
    Zacks2 days ago

    Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand

    The FDA approval for MitraClip G4 is expected to enhance Abbott's (ABT) cardiac treatment portfolio.

  • NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results
    PR Newswire3 days ago

    NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results

    SAN DIEGO, July 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its second quarter 2019 earnings results on Tuesday, July 30, 2019 after the close of the market. NuVasive will hold a conference call on Tuesday, July 30, 2019, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the second quarter 2019. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • ABT or BIO: Which Stock Has Better Potential Right Now?
    Zacks3 days ago

    ABT or BIO: Which Stock Has Better Potential Right Now?

    Abbott (ABT) scores higher than Bio-Rad (BIO) in terms of valuation and one-year price performance.

  • Here's Why You Should Hold Onto Neogen (NEOG) Stock Now
    Zacks3 days ago

    Here's Why You Should Hold Onto Neogen (NEOG) Stock Now

    Investors' trust continues to be high in Neogen (NEO), thanks to strength in its Food Safety and Genomic businesses.

  • GlobeNewswire3 days ago

    Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.

    NEWPORT BEACH, Calif., July 15, 2019 -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,.

  • TFX or STE: Which is a Better Investment Pick Right Now?
    Zacks6 days ago

    TFX or STE: Which is a Better Investment Pick Right Now?

    STERIS (STE) scores higher than Teleflex (TFX) when it comes to valuation and one-year price performance.

  • NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques
    PR Newswire7 days ago

    NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques

    SAN DIEGO, July 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company is continuing its commitment to the Scoliosis Research Society as a Double Diamond sponsor of the 26th International Meeting on Advanced Spine Techniques (IMAST) being held July 17-20, 2019 at the RAI Amsterdam Convention Centre. NuVasive will highlight its leading solutions for adult and pediatric complex spine surgery and comprehensive approach to lateral single-position surgery with the X360™ system integrated with Surgical Intelligence™. During the meeting, NuVasive will host a lunch workshop, Advanced Techniques in Complex Deformity Procedures, presented by Tyler Koski, MD, and Christopher Shaffrey, MD, on July 18, 2019 from 1:05 to 2:05 p.m. CEST in room G105.

  • NuVasive (NUVA) Launches Pulse Integrated Technology Platform
    Zacks7 days ago

    NuVasive (NUVA) Launches Pulse Integrated Technology Platform

    The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.

  • NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery
    PR Newswire8 days ago

    NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery

    Early clinical experience demonstrates the Pulse system's utility to improve workflow, reduce surgical variability and increase reproducibility of surgical outcomes SAN DIEGO , July 10, 2019 /PRNewswire/ ...

  • At US$55.78, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
    Simply Wall St.8 days ago

    At US$55.78, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

    NuVasive, Inc. (NASDAQ:NUVA), which is in the medical equipment business, and is based in United States, saw...

  • Here’s What Hedge Funds Think About NuVasive, Inc. (NUVA)
    Insider Monkey28 days ago

    Here’s What Hedge Funds Think About NuVasive, Inc. (NUVA)

    How do we determine whether NuVasive, Inc. (NASDAQ:NUVA) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that […]

  • Was NuVasive, Inc.'s (NASDAQ:NUVA) Earnings Growth Better Than The Industry's?
    Simply Wall St.28 days ago

    Was NuVasive, Inc.'s (NASDAQ:NUVA) Earnings Growth Better Than The Industry's?

    After looking at NuVasive, Inc.'s (NASDAQ:NUVA) latest earnings announcement (31 March 2019), I found it useful to...

  • NuVasive Grows on Strong Product Adoption Amid Pricing Woe
    Zackslast month

    NuVasive Grows on Strong Product Adoption Amid Pricing Woe

    Introduction of multiple products within the Spinal Hardware, balanced revenue growth across key operating segments and robust international sales perk up NuVasive's (NUVA) share price.

  • NuVasive Launches Titanium Spine Implant Modulus TLIF-O
    Zackslast month

    NuVasive Launches Titanium Spine Implant Modulus TLIF-O

    The launch of Modulus TLIF-O is expected to boost the AMS portfolio of NuVasive (NUVA).

  • NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion
    PR Newswirelast month

    NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

    SAN DIEGO, June 17, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-O, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This further expands the application of the Company's Advanced Materials Science™ (AMS) portfolio to more of its procedural offerings and the most commonly performed procedure in the spine industry. Modulus TLIF-O features porous surface technology that, based on pre-clinical data, provides a favorable environment for bone in-growth and bone on-growth, and consistently achieves stronger osseointegration than solid implants with smooth or rough surfaces.1-4 The porous and roughened endplate design promotes new bone on-growth at four weeks and demonstrates the greatest integration strength by 12 weeks compared to alternative implant materials.5 Modulus TLIF-O's lattice structure is optimized for each implant size through NuVasive's proprietary algorithm that balances strength and radiolucency, while also mimicking the stiffness of bone.5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.

  • NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards
    PR Newswirelast month

    NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards

    SAN DIEGO, June 12, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the Radiological, Imaging and Electromechanical Devices category at the 2019 Medical Design Excellence Awards (MDEA) held in New York City on June 11, 2019. The LessRay platform is built on a proprietary algorithm that captures and enhances low-dose, low-quality images to produce images with similar diagnostic capabilities as conventional full-dose images. This technology has the ability to reduce radiation emissions to the operating room (OR) staff and patient by 75 percent compared to standard fluoroscopy.1 Additionally, LessRay contains a number of surgical efficiency features designed to save time during spine surgery, which can decrease time under anesthesia for the patient.

  • Markitlast month

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVAView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for NUVA with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on May 28. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $118 million over the last one-month into ETFs that hold NUVA are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report?
    Zacks2 months ago

    Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report?

    NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System
    PR Newswire2 months ago

    NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System

    SAN DIEGO, May 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions announced today that the Company's SpineTRACK Registry submitted successful quality performance data to the Centers of Medicare & Medicaid Services (CMS) on behalf of healthcare providers at Southern Oregon Neurosurgical & Spine Associates (SONSA) for the Merit-based Incentive Payment System (MIPS). As a result, SONSA providers are eligible for a positive adjustment of up to seven percent on all Medicare reimbursements for the 2020 payment year.